| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |